Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant
Abstract We developed a SARS-CoV-2 spike subunit vaccine formulation containing dual TLR ligand liposome adjuvant. The vaccine-induced robust systemic neutralizing antibodies and completely protected mice from a lethal challenge. Two immunizations protected against lung injury and cleared the virus...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/da4da1c7c88a4956b31769225afbc2c2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|